Bath scientists stabilise vaccine proteins with ensilication
A new system for delivering vaccines to children in low-income nations has taken a vital step forward, thanks to groundbreaking work at the University of Bath
Vaccines are notoriously difficult to transport to remote or dangerous places, as they spoil when not refrigerated. Formulations are safe between 2°C and 8°C, but at other temperatures the proteins start to unravel, making the vaccines ineffective. As a result, millions of children around the world miss out on life-saving inoculations.
However, scientists have now found a way to prevent warmed-up vaccines from degrading. By encasing protein molecules in a silica shell, the structure remains intact even when heated to 100°C, or stored at room temperature for up to three years.
The technique for tailor-fitting a vaccine with a silica coat – known as ensilication – was developed by a Bath team in collaboration with the University of Newcastle. This pioneering technology was seen to work in the lab two years ago, and now it has demonstrated its effectiveness in the real world too.
The researchers explain the significance of their findings
In their latest study, published in the journal Scientific Reports, the researchers sent both ensilicated and regular samples of the tetanus vaccine from Bath to Newcastle by ordinary post (a journey time of over 300 miles, which by post takes a day or two). When doses of the ensilicated vaccine were subsequently injected into mice, an immune response was triggered, showing the vaccine to be active. No immune response was detected in mice injected with unprotected doses of the vaccine, indicating the medicine had been damaged in transit.
Dr Asel Sartbaeva, who led the project from the University of Bath’s Department of Chemistry, said: “This is really exciting data because it shows us that ensilication preserves not just the structure of the vaccine proteins but also the function – the immunogenicity.”
“This project has focused on tetanus, which is part of the DTP (diphtheria, tetanus and pertussis) vaccine given to young children in three doses. Next, we will be working on developing a thermally-stable vaccine for diphtheria, and then pertussis. Eventually we want to create a silica cage for the whole DTP trivalent vaccine, so that every child in the world can be given DTP without having to rely on cold chain distribution.”
Cold chain distribution requires a vaccine to be refrigerated from the moment of manufacturing to the endpoint destination.
Silica is an inorganic, non-toxic material, and Dr Sartbaeva estimates that ensilicated vaccines could be used for humans within five to 15 years. She hopes the technology to silica-wrap proteins will eventually be adopted to store and transport all childhood vaccines, as well as other protein-based products, such as antibodies and enzymes.
“Ultimately, we want to make important medicines stable so they can be more widely available,” she said. “The aim is to eradicate vaccine-preventable diseases in low income countries by using thermally stable vaccines and cutting out dependence on cold chain.”
Currently, up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. According to the World Health Organisation (WHO), 19.4 million infants did not receive routine life-saving vaccinations in 2018.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Ten Covid-19 vaccines seen by mid-year: Global pharma groupon November 27, 2020 at 9:56 pm
Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, head of global pharma group said.
- Hungary Looks East For Coronavirus Vaccineson November 27, 2020 at 8:37 pm
An Aeroflot delivery of Russia's Sputnik V coronavirus vaccine to EU member Hungary last week has sparked new criticism at home and abroad of Prime Minister Viktor Orban's go-it-alone policies. "We ...
- Vaccines for 6.4mil M’sians next yearon November 27, 2020 at 3:00 pm
Malaysians are likely to have access to free Covid-19 vaccines as early as next January, says the Prime Minister. Read full story ...
- 'The buck stops with her': June Raine to make call on UK's Covid vaccineson November 27, 2020 at 12:07 pm
Head of MHRA has ‘devoted whole life to public health’, says former colleague ...
- US Operation Warp Speed Backed Vaccines For Whole Worldon November 27, 2020 at 11:58 am
President Donald Trump's announcement in May of plans to develop a Covid-19 vaccine by year's end is near realization -- despite a setback among one of the six candidates that the US supported. The ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Mass Spectrometry and Illicit Drug Testing: Analytical Challenges of the Anti-doping Laboratorieson November 24, 2020 at 4:00 pm
and the derivatization of the final extract to yield more thermally stable and volatile derivatives) made the detection of AAS in urine possible, with a window of detectability that for some ...
- Biasing That Transistor Part 4: Don’t Forget The FETon November 22, 2020 at 4:00 pm
Over the recent weeks here at Hackaday, we’ve been taking a look at the humble transistor. In a series whose impetus came from a friend musing upon his students arriving with highly developed ...
- Achieving Efficacy and Sterility in Flexible Packagingon November 22, 2020 at 4:00 pm
Packaging plays an important role in many industries, but few applications are as demanding as those found in the medical device and diagnostic industry. Packaging for medical devices may lack the ...
- Inovio: The COVID Vaccine Race Is Not Yet Overon November 19, 2020 at 6:50 am
Also, by that time, investors will have realized that vaccine development, in addition to effectiveness is about producing a thermally stable vaccine capable of being transported easily in order ...
- The Daily Reflectoron November 18, 2020 at 11:09 pm
If the vaccine is not thermally stable, inoculation sites would need to be set up at clinics like the one at the Health Department. If the vaccine is thermally stable, sites could be opened across ...